Tag: Fresenius Kabi PharmaceuticalsSort
APCVZ, HIRU.PK, PESI, QBAK, - Fresenius Kabi Pharmaceuticals, Hiru Corporation, Perma-Fix Environmental Services
Fresenius Kabi Pharmaceuticals (NASDAQ:APCVZ) previously reported that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately. Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc.
PTSH.OB, AVOT.PK, APCVZ, FCEL, ENER, - PTS, American Video Teleconferencing, Fresenius Kabi Pharmaceuticals, FuelCell Energy
PTS, Inc. (PTSH.OB) previously entered into a Share Exchange Agreement pursuant to which PTSH will acquire 70% of ThinLine Technology Group at the closing. Closing shall occur as soon as PTSH receives satisfactory audited financials from ThinLine, but not later than December 31, 2010.